Search results for: 'development in the dr value chain'

Although the telecoms landscape in APAC has changed a lot since the onset of the COVID-19 pandemic, data as a key driver of traffic and 5G monetization as the industry’s biggest bottleneck remain important trends impacting the industry. As 5G enterprise develops, enhanced mobile broadband (eMBB) is expected to continue to impact the mobile operator...

Rife geopolitical tensions and multiple external shocks during the past few years have been rapidly transforming global supply chains and pushing firms to take strategic site-selection decisions. The need for economic resiliency is fostering a paradigm shift as companies are directing investments into the establishment of local and regional manufac...

According to the Centers for Medicare and Medicaid Services (CMS), value-based care (VBC) programs reward healthcare providers with incentive payments for the quality of care they provide Medicare patients. These programs are part of its larger CMS quality strategy to reform healthcare delivery and payment. Value-based programs support 3 aims: b...

Traditional carsharing refers to short-term vehicle rentals where users can pick up and return vehicles either at fixed stations (station-based) or at flexible locations within a designated area (free-floating). In this model, carsharing operators typically own and manage the vehicle fleets. Zone-based operators primarily support station-based serv...

The growing need to achieve deep decarbonization in hard-to-abate industries and to address climate change is driving the large-scale deployment of carbon dioxide utilization technologies. Efficient carbon utilization technologies are required to scale up emission reduction to gigatons per annum in the coming years to meet Net-Zero Targets while re...

This research service analyses the mobility market value chain in detail and discusses the expected trends. The study delves into evolving business models, market consolidations and partnerships, and advanced technology trends shaping the market. It provides the market trends and outlines potential growth avenues for the near future.--BEGIN PROMO--...

By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...

10 May 2023  |  Global  |  Market Research

Growth Opportunities in the Biologics Contract Development and Manufacturing Organization Sector

Value Chain Expansion to Support Next generation Biologics Drives Future Growth Potential

Infographics

×

This research service provides an overview of the global biologics contract development and manufacturing organization (bio-CDMO) market and a 6-year market revenue forecast (2023 to 2028). The geographic scope covers three key regions, namely North America (NA); Europe; and Asia-Pacific (APAC). The report offers a detailed segment analysis of...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....